[MYGN] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
05-Feb-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -9.20%
YoY- 43.74%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 196,500 193,300 184,393 204,060 149,140 122,811 100,440 11.82%
PBT 12,100 45,000 37,940 84,144 56,985 46,783 39,054 -17.72%
Tax 6,200 14,700 13,909 33,784 21,949 18,487 14,863 -13.54%
NP 5,900 30,300 24,031 50,360 35,036 28,296 24,191 -20.93%
Tax Rate -51.24% -32.67% -36.66% -40.15% -38.52% -39.52% -38.06% -
Total Cost 190,600 163,000 160,362 153,700 114,104 94,515 76,249 16.48%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 3.00 15.68 13.03 24.68 23.49 23.04 24.09 -29.31%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS 0.09 0.43 0.33 0.67 0.43 0.33 0.26 -16.19%
EPS Diluted 0.09 0.41 0.32 0.66 0.42 0.33 0.26 -16.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.